Le Lézard
Classified in: Health
Subjects: MAV, PSF, CPG, CMG, CFG

/R E P E A T -- Media Advisory - Governments of Canada and Ontario, along with City of Toronto, to announce major investment/


TORONTO, March 30, 2021 /CNW/ - The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, together with the Honourable Patty Hajdu, Minister of Health; the Honourable Doug Ford, Premier of Ontario; the Honourable Victor Fedeli, Ontario Minister of Minister of Economic Development, Job Creation and Trade; and His Worship, John Tory, Mayor of Toronto, will announce a significant investment to support Canada's future pandemic preparedness.

A media availability by teleconference will follow the announcement.

Date:

Wednesday, March 31, 2021



Time:

10:00 a.m. (ET)



Location:

1755 Steeles Avenue West


North York, Ontario

Note to media:

In order to ensure compliance with local public health guidance, only one camera person and one photographer will be authorized on site. As such, media outlets are invited to set up a camera and photography pool.

Media outlets are asked to confirm their virtual participation by contacting ISED Media Relations at [email protected] no later than 8:00 a.m. (ET) on Wednesday, March 31, 2021.

The event will be live-streamed on Innovation, Science and Economic Development Canada's Facebook page: Canadian Innovation.

In-person attendees will be required to wear a face covering at all times and to remain at least two metres apart from each other.

Stay connected

Find more services and information at Canada.ca/ISED.

Follow Innovation, Science and Economic Development Canada on social media.
Twitter: @ISED_CA, Facebook: CanadianInnovation, Instagram: @CDNinnovation and LinkedIn

SOURCE Innovation, Science and Economic Development Canada


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: